about
Chronic proton pump inihibitor therapy and calcium metabolismVitamin D and intestinal calcium transport after bariatric surgery.Clinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors.Osteoporosis and gastrointestinal disease.Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort studyFasting and postprandial spot urine calcium-to-creatinine ratios do not detect hypercalciuria.Hypomagnesaemia associated with long-term use of proton pump inhibitorsA Proton Pump Inhibitor's Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized StudyAromatase inhibitors and calcium absorption in early stage breast cancer.Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.The Indications, Applications, and Risks of Proton Pump InhibitorsTreatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial.Apical acidity decreases inhibitory effect of omeprazole on Mg(2+) absorption and claudin-7 and -12 expression in Caco-2 monolayers.Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients.Effects of rabeprazole on bone metabolic disorders in a gastrectomized rat modelFactors associated with calcium absorption in postmenopausal women: a post hoc analysis of dual-isotope studiesThe Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.The risks of PPI therapy.Prescribing proton pump inhibitors: is it time to pause and rethink?Fracture risk and bone mineral density reduction associated with proton pump inhibitors.Gastric acid, calcium absorption, and their impact on bone health.The role of the gastrointestinal tract in calcium homeostasis and bone remodeling.The association between drugs frequently used by the elderly and vitamin D blood levels: a review of observational and experimental studies.Pharmacokinetic evaluation of esomeprazole for the treatment of gastroesophageal reflux disease.Adverse skeletal effects of drugs - beyond Glucocorticoids.Calcium Pyrophosphate Deposition Disease and Associated Medical Comorbidities: A National Cross-Sectional Study of US Veterans.Pantoprazole, a proton pump inhibitor, does not prevent botulinum toxin induced disuse osteopenia in mice.Proton-pump inhibitors: understanding the complications and risks.Proton pump inhibitors and risk of bone fractures.Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity.Vitamin B12 Deficiency Induced by the Use of Gastric Acid Inhibitors: Calcium Supplements as a Potential Effect Modifier.Effects of the Histamine 1 Receptor Antagonist Cetirizine on the Osteoporotic Phenotype in H(+) /K(+) ATPase Beta Subunit KO Mice.Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use.Proton Pump Inhibitors: Are They a Real Threat to the Patient?
P2860
Q27016636-B5F63ED5-D41D-48F8-BA42-A685DFAD5EFCQ30239903-B25524C1-EB1B-4163-BE25-75AADB4E462BQ31157434-B389A768-F0B0-4220-9382-89A9EC45B687Q34178759-5ED491AB-BF3C-4C81-8155-7BFAA6164543Q34186827-EFDAD50F-35B1-4B99-8A4F-66879FF3DD52Q35173200-9D8EF025-21EF-464A-8A97-A699CB6DE990Q35719101-5C9BE470-5385-4EBE-AA46-CEC34718DA3CQ35807352-0B037B49-261B-4FAA-9E03-8FB7D08024A3Q35923371-081E374F-BE9F-4446-8FDA-EAB1C1900A3AQ36037123-C67FB22F-6B46-4A31-BC39-7F6E614D78DFQ36037270-71DBA072-0E8F-460F-8772-9FDCC12910EAQ36075131-819F818E-A98B-4CDA-B7A3-3FAF96D2807AQ36091187-1B9D7216-8C16-4A9B-8CFE-57EEC8AE1DE4Q36124085-EF7CAAA4-A430-4F1A-8548-2B6444D1F883Q36431083-6280B8E7-6136-48E7-B8B7-6B023EF14129Q36805116-6CD4FA8F-D8B8-4DB5-9EC1-D0C2F96BDAF4Q37001665-536DE0E1-C123-46B4-A9E2-BB902CFAC615Q37707037-9F274171-B106-4E28-8703-15ECB3B8E23AQ37709906-5C906657-4973-4DDD-BE7A-A89CAB81117BQ37983706-41592D82-F596-4FFC-9AFE-07BC22634F6CQ37987204-5AD05893-E05B-4B26-8E25-4CC1B3EA6FA2Q37990890-4DD101F7-568C-4E41-99EF-A9F65A2CAE08Q38072903-E94A55E7-82D8-4054-A571-3E70562954C4Q38093799-6F15335C-455E-4079-964A-2DBDF2917E08Q38175361-212686E0-4F19-4796-B52E-D3FD904341ABQ38229080-040B27DF-1FF0-4C16-B8C3-8DCACCF6BF54Q38231316-ADE32D40-8DB4-4917-919F-9192608EB37EQ39145003-38D12BC7-3364-4834-B621-8486BE10B7D4Q41707081-0C2DE648-F840-4E10-80EC-C3F4F635DEF8Q41996131-DB72CC81-ECB6-4100-9206-3061FCB4F119Q43426137-1BAC33D8-AB42-4764-833B-CE72812DE544Q45773103-FFAC4269-4D75-47EF-9640-4CC1CC327216Q47818973-A1C83AA0-F280-4DA3-8CB8-BF9D50CAB087Q50931979-4D6E59E2-E2E1-4D34-8722-B2E14DD61008Q55493690-35F5B4BA-ACB8-4749-AF81-78E2A9A3C850Q57494425-C506762C-8289-4C9B-8E5B-54E8F105D9C3
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Do proton pump inhibitors decrease calcium absorption?
@ast
Do proton pump inhibitors decrease calcium absorption?
@en
type
label
Do proton pump inhibitors decrease calcium absorption?
@ast
Do proton pump inhibitors decrease calcium absorption?
@en
prefLabel
Do proton pump inhibitors decrease calcium absorption?
@ast
Do proton pump inhibitors decrease calcium absorption?
@en
P2093
P2860
P356
P1476
Do proton pump inhibitors decrease calcium absorption?
@en
P2093
Amy L Alvig
Andrea N Jones
Karen E Hansen
Kristina L Penniston
Lisa A Davis
Martin M Shafer
Mary J Lindstrom
Toni E Ziegler
P2860
P304
P356
10.1002/JBMR.166
P577
2010-06-24T00:00:00Z